Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


August 29, 2015 1:56 PM ET

Biotechnology

Company Overview of Lux Biosciences, Inc.

Company Overview

Lux Biosciences, Inc. operates a biotechnology company which develops and commercializes medications for ophthalmic diseases in the United States and internationally. Its products comprise LUVENIQ, an oral form of calcineurin inhibitor voclosporin, which is used for the treatment of non-infectious uveitis; LX214, a topical formulation that contains mixed nanomicelles of voclosporin for ophthalmic use; LX212, a bioerodible polymer implant containing voclosporin; and LX213, a bioerodible/isotechnika implant. The company was incorporated in 2005 and is based in Jersey City, New Jersey.

3 Second Street

Harborside Financial Center Plaza 10

14th Floor

Jersey City, NJ 07302

United States

Founded in 2005

Phone:

201-946-0551

Fax:

201-946-0552

Key Executives for Lux Biosciences, Inc.

Co-Founder and Chief Operating Officer
President of Europe Region and Managing Director of Lux Biosciences GmbH
Compensation as of Fiscal Year 2015.

Similar Private Companies By Industry

Company Name Region
Inhibitex, Inc. United States
Applied Molecular Transport, LLC United States
Xytis, Inc. United States
Pacific Biotech, Inc. United States
Serologicals Proteins, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Lux Biosciences, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.